Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Advances in Antithrombotic Therapy: Insights from the ESC Guidelines on Management of Non-ST Elevation ACS |
Yaling Han | General Hospital of Northern Theater Command |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Interpretation of Chinese Expert Consensus on Antithrombotic Management of Patients with Atrial Fibrillation and Coronary Artery Disease |
Peng Qu | The Second Affiliated Hospital of Dalian Medical University |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Antithrombotic Therapy in CAD Patients with COVID-19 |
Hesong Zeng | Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
How to Reduce the Risk of Stent Thrombosis in Patients Treated with Bio-Resorbable Stent: Insights from the Chinese Expert Consensus on the Clinical Application of Coronary Bioresorbable Scaffold |
Yaojun Zhang | Xuzhou Cancer Hospital |
10:21-10:30 | 10:21-10:30 |
Discussion |